Macquarie University researchers have discovered new information about how oral cancer cells may block the body’s immune response. This could lead to better treatments for this aggressive disease.
Despite failing its PhII test, Xenon sees future for major depression drug
Xenon Pharmaceuticals’ major depressive disorder drug candidate didn’t reach statistical significance versus placebo in the primary endpoint of a mid-stage trial, but the Canadian biotech
November 28, 2023